Description
Developer of a polymeric platform intended to treat tuberculosis. The company's polymeric platform offers a multi-medicine system for nanomedicine innovation to maximize the clinical impact of therapeutics, enabling patients to have fewer drug regimens with improved results.
Contact Information
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
1. Accelerator/Incubator | 01-Apr-2015 | Completed | Startup |
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|---|---|---|---|---|
Accelerate Cambridge | Accelerator/Incubator | 000 0000 | 000000 0 |